Diabetes mellitus tipo 1 en una paciente con hepatitis c durante el tratamiento con interferón alfa. Primer caso comunicado en Cuba

Ustariz García, Catalino R.
Rev. cuba. hematol. inmunol. hemoter ; 29(3): 284-288, jul-sep. 2013.
Artículo en Español | LILACS | ID: lil-689639

Documentos relacionados

  1. Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.
  2. Adenoviral gene therapy for bladder cancer.
  3. Inhibiting cell-to-cell transmission to reach HDV cure: The importance of IFN-α.
  4. Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies.
  5. You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response.
  6. Sequence Effect of Peptide-Based Materials on Delivering Interferon-α (IFN-α): A Molecular Dynamic Perspective.
  7. [Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].
  8. From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.
  9. Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
  10. Role of IFN-α in Rheumatoid Arthritis.